Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03104699
Title Phase 1 / 2 Study of AGEN2034 in Advanced Tumors and Cervical Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Agenus Inc.
Indications

Advanced Solid Tumor

cervical cancer

Therapies

Balstilimab

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL


No variant requirements are available.